Search:
Browse
Collection All
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
Listed communities
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

Helmholtz Zentrum für Infektionsforschung Repository > HIPS > Division Wirkstoffdesign und Optimierung (DDOP) > Publications of the divsion Wirkstoffdesign und Optimierung (DDOP) > Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.


Please use this identifier to cite or link to this item: http://hdl.handle.net/10033/237153
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!



Title: Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma.
Authors: Bihrer, Verena
Waidmann, Oliver
Friedrich-Rust, Mireen
Forestier, Nicole
Susser, Simone
Haupenthal, Jörg
Welker, Martin
Shi, Ying
Peveling-Oberhag, Jan
Polta, Andreas
von Wagner, Michael
Radeke, Heinfried H
Sarrazin, Christoph
Trojan, Jörg
Zeuzem, Stefan
Kronenberger, Bernd
Piiper, Albrecht
Affiliation: Department of Medicine I, University of Frankfurt/M., Frankfurt, Germany.
Citation: Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma. 2011, 6 (10):e26971 PLoS ONE
Journal: PloS one
Issue Date: 2011
URI: http://hdl.handle.net/10033/237153
DOI: 10.1371/journal.pone.0026971
PubMed ID: 22066022
Abstract: MicroRNA-21 (miR-21) is up-regulated in tumor tissue of patients with malignant diseases, including hepatocellular carcinoma (HCC). Elevated concentrations of miR-21 have also been found in sera or plasma from patients with malignancies, rendering it an interesting candidate as serum/plasma marker for malignancies. Here we correlated serum miR-21 levels with clinical parameters in patients with different stages of chronic hepatitis C virus infection (CHC) and CHC-associated HCC.
Type: Article
Language: en
MeSH: Alanine Transaminase
Aspartate Aminotransferases
Bilirubin
Biological Markers
Carcinoma, Hepatocellular
Cohort Studies
Female
Hepatitis C, Chronic
Humans
Inflammation
Liver Neoplasms
Male
MicroRNAs
Middle Aged
Multivariate Analysis
Necrosis
Reproducibility of Results
Serum Albumin
gamma-Glutamyltransferase
ISSN: 1932-6203
Appears in Collections: Publications of the divsion Wirkstoffdesign und Optimierung (DDOP)

Files in This Item:
File Description Size Format View/Open
Bihrer et al_final.pdfOpen Access publication431KbAdobe PDFThumbnail
View/Open

Related articles on PubMed
bullet
Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection.
Bihrer V, Friedrich-Rust M, Kronenberger B, Forestier N, Haupenthal J, Shi Y, Peveling-Oberhag J, Radeke HH, Sarrazin C, Herrmann E, Zeuzem S, Waidmann O, Piiper A
2011 Sep
bullet
bullet
bullet
Clinical implications of alpha-fetoprotein in chronic hepatitis C.
Tai WC, Hu TH, Wang JH, Hung CH, Lu SN, Changchien CS, Lee CM
2009 Mar
bullet
Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies.
Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, Run W, Tian L, Jia X, Gao Y
2011 Mar
See all 172 articles

This item is licensed under a Creative Commons License
Creative Commons

All Items in HZI are protected by copyright, with all rights reserved, unless otherwise indicated.